In the News
powered by Ovast-
Pfizer, Medivation End Drug Development Deal
miamiherald.com 4 weeks, 1 day agoIn a major setback for patients and doctors, drugmakers Pfizer Inc. and Medivation Inc. have halted development of a potential Alzheimer's disease treatment after the drug for a second time yielded disappointing results in a late-stage clinical study.
-
Pfizer, Medivation Pull Plug On Alzheimer's Drug - ABC News
google.com 4 weeks, 1 day agoABC News Pfizer, Medivation Pull Plug on Alzheimer's Drug ABC News (ABCNEWS.com) Another failure in phase III clinical testing has finally sent the investigational Alzheimer's disease drug dimebon to the trash heap, according to its commercial sponsors. Pfizer and Medivation, the companies co-developing the drug, ... Pfizer, Medivation end drug deal Alzheimer's drug fails for Pfizer, Medivation Dimebon drug trial fails to meet primary endpoint: Medivation, Pfizer report -


Loading More Stories